Back to search
Unresectable Sinonasal Tumors
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Unresectable Sinonasal Tumors trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Unresectable Sinonasal Tumors trials you may qualify forThis phase I trial tests the safety, side effects, and best dose of camonsertib in combination with stereotactic body radiation therapy in controlling disease i…
This prospective, multicenter clinical study aims to evaluate the efficacy and safety of neoadjuvant therapy with MRG003 (Becotatug vedotin) combined with epiru…
This study is being done to test a new treatment plan for large tumors in the sinus or nasal cavity that will include endoscopic surgery plus chemotherapy and p…
This phase I trial evaluates the best dose, possible benefits and/or side effects of combination therapy with elimusertib (BAY 1895344), stereotactic body radia…
Sinonasal tumors are rare diseases, as they account for the 0.2 % - 0.8 % of all tumors. For patients with inoperable tumors, the prognosis is poor and the curr…